Home Future 100: Unveiling China's Next Generation of Skin Health Unicorns

Future 100: Unveiling China's Next Generation of Skin Health Unicorns

Nov 30, 2025 21:20 CST Updated 21:20

From November 27 to 29, themed “Beauty Power Crosses Boundaries, Professionalism Knows No Limits”SIA2025 Scientific Skincare Innovation Alliance Annual ConferenceSuccessfully held in Shanghai. The conference wasShanghai Science and Technology Exchange CenterUnder the guidance of, byShanghai Kemeng Skin Health Service Technology Innovation Promotion Center (SIA Kemeng)Hosted by Umai Tech and co-organized by Hongsheng Capital, with support from Meichuang Jingjie and other organizations.


The conference innovatively adopts“One Body, Two Wings”agenda architecture,Taking the Main Forum as the “Core”, continuously focusing on the three core tasks of “co-creation between medical practice and research, translation of scientific achievements, and science communication,” thereby establishing a differentiated foundation distinct from traditional industry conferences.


"Two Wings" Thematic ConferenceServing as a driving engine, one of the key initiatives—the Future Dermatology Conference and the Release of the “Future 100: Top 100 Enterprises in Skin Health” List (hereinafter referred to as the “Future Dermatology Conference”)—concluded successfully on November 29. The Future Dermatology Conference was held under the guidance of three organizations: the SIA Science Alliance, the Jiangnan Beauty Industry Research Institute in the Shanghai Yangtze River Delta Integration Demonstration Zone, and the Shanghai Beauty and Health Industry Association. It was organized by Umai Technology, a value platform for Chinese dermatologists, and seasoned investment and financing institutions in the field of skin health.Hongsheng Capital, andMeichuang Jingjie(Jing'an District Industrial Platform) co-hosted,Shanghai Skin Health Proof of Concept Center, VCBeat, Chaogui Institute,andDongfang Meigu Institute of DermatologyCo-organized, with the beauty business media Meipai specially invited as the strategic cooperation media.


It is worth mentioning that thisFuture Dermatology CongressGrandly Unveiled“Future 100 – Top 100 Companies Shaping the Future of Skin Health (abbreviated as: Future 100 List)”. This list marks the first precise focus on the industry’s “mid-tier strength” and “hidden champions,” selecting enterprise samples with the greatest growth potential through a combination of authoritative professional evaluation and market performance. The awarded enterprises come from"Consumer Goods," "Medical Aesthetics Technology," "Biotechnology"Three Major Sectors, Comprehensive Coverage“Three Products and One Device”Business Format.


The Future Top 100 List aims to build a bridge connecting innovative enterprises with capital and policy, ensuring that professional technological strengths are truly “seen” and facilitating their value leap from “recognition” to “investment” and then to “rapid growth,” thereby jointly shaping the new ecosystem and future landscape of China’s skin health industry.


The freshly released rankings are as follows:

1.jpg2.jpg3.jpg


The selection criteria for the three major sectors—“Consumer Goods,” “Medical Aesthetic Technology,” and “Biotechnology”—in the above rankings were developed through rigorous evaluation and discussion by authoritative organizations, including professional investment institutions, government service agencies, and experts in the beauty and health industry. These criteria fully account for the distinct characteristics of enterprises within each sub-category, enabling differentiated assessments within a unified framework to ensure the comprehensiveness and professionalism of the selection process:


1. Consumer Goods Companies

Scope of Applicant Enterprises:

① Beauty and personal care consumer brands, including skincare, hair and body care, personal hygiene, and oral care;

② Revenue scale of over 100 million yuan (under 2 billion yuan);

③ Non-listed companies;

④ By enterprise; enterprises registered in mainland China (non-foreign-funded);

⑤ Emerging companies with active capital market presence and future growth potential;

Basic Eligibility Criteria for Applicant Enterprises:

Established for ≥3 years, with clearly defined core cosmetic products, and no record of major negative regulatory penalties

Evaluation Dimensions:

Investment Value: Brand Scale and Growth Potential, Channel Coverage Capability, Star Product Performance, Operational Efficiency

Technical Potential: Product Innovation Capability, R&D Investment, and Technological Influence

Industry Perception: Brand Awareness, Consumer Reputation, and Peer Evaluation

Compliance and Sustainability: Product Quality and Safety, Social Responsibility, and Long-Term Development Strategy


2. Medical Aesthetics Technology Enterprise Ranking

Scope of Applicant Enterprises:

Aesthetic Medicine-Related and Dermatological Technology Enterprise

Financing and investment records and activity level in the past three years

Basic Threshold for Applicant Enterprises:

Record of investments by institutions or industrial capital in the past two years

With a clear focus on cosmetics or medical aesthetic technologies as its core business

No Record of Major Negative Regulatory Penalties

Evaluation Dimensions:

Investment Value: Commercialization Capability, Recent Financing Transaction Amounts, and Future Market Potential

Technical Potential: Technological Leadership, Originality of Technical Route, and Progress in Regulatory Submission

Industry Perception: Professional Reputation, Brand Equity, Industry Standing

Compliance and Sustainability: Medical Safety Compliance, Clinical Validation Data, and Long-Term Technological Development


3. Biotechnology Companies

Scope of Applicant Enterprises:

Biotechnology R&D and Raw Material Technology Enterprises

Financing and Investment Records and Activity in the Past Three Years

Basic Eligibility Criteria for Applicant Companies:

Investment records from institutions or industrial capital in the past two years

Achievements in Innovative Technology R&D

No Record of Major Negative Regulatory Penalties

Evaluation Dimensions:

Investment Value: Commercialization Prospects of Technology, Customer Case Studies, Recent Financing Amounts

Technical Potential: Core Technological Advantages, R&D Team, Technological Achievements, and Technological Originality

Industry Insights: Expert Evaluations, Technological Influence, and Collaboration Networks

Compliance and Sustainability: Technical Safety Compliance, Intellectual Property Protection, and Long-Term R&D Investment

Note: A few exceptional cases have been voluntarily disclosed by the applicant companies.


This time“Future 100: Top 100 Companies in Skin Health”The release not only recognizes the long-term dedication of high-quality enterprises but also clearly outlines the development trajectory of the beauty and health industry, centered on “technology as the core, compliance as the foundation, and users at the heart.” In the future, we aim to continuously identify and support more high-potential unicorn enterprises in the beauty and health sector, jointly ushering in the next era of consumer dividends.